Tg Therapeutics (TGTX) Work In Process (2023 - 2025)

Tg Therapeutics' Work In Process history runs 3 years deep, the most recent figure standing at $121.8 million for Q3 2025.

• In Q3 2025, Work In Process rose 62.47% year-over-year to $121.8 million; the TTM figure through Sep 2025 stood at $121.8 million (up 62.47% YoY), while the FY2024 annual figure was $68.4 million, up 118.84% from the prior year.
• Work In Process for Q3 2025 stood at $121.8 million, down from $129.2 million in the prior quarter.
• The five-year high for Work In Process was $142.9 million in Q1 2025, with the low at $27.1 million in Q1 2023.
• The 3-year median for Work In Process is $74.1 million (2024), against an average of $73.5 million.
• The sharpest annual moves came in 2024 and 2025: Work In Process soared 172.99% in 2024, then jumped 62.47% in 2025.
• Tg Therapeutics' Work In Process stood at $31.2 million in 2023, then surged by 118.84% to $68.4 million in 2024, then soared by 78.16% to $121.8 million in 2025.
• Business Quant data shows TGTX's Work In Process at $121.8 million in Q3 2025, $129.2 million in Q2 2025, and $142.9 million in Q1 2025.